Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease.

Puleston J, Cooper M, Murch S, Bid K, Makh S, Ashwood P, Bingham AH, Green H, Moss P, Dhillon A, Morris R, Strobel S, Gelinas R, Pounder RE, Platt A.

Aliment Pharmacol Ther. 2005 Jan 15;21(2):109-20.

2.

Coordinate upregulation of interleukin-8 and growth-related gene product-alpha is present in the colonic mucosa of inflammatory bowel.

Imada A, Ina K, Shimada M, Yokoyama T, Yokoyama Y, Nishio Y, Yamaguchi T, Ando T, Kusugami K.

Scand J Gastroenterol. 2001 Aug;36(8):854-64.

PMID:
11495082
3.
4.

Review article: Chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease?

van Deventer SJ.

Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:116-20; discussion 120-1. Review.

5.

Elevated cell-associated levels of interleukin 1beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease.

Grottrup-Wolfers E, Moeller J, Karbach U, Muller-Lissner S, Endres S.

Eur J Clin Invest. 1996 Feb;26(2):115-22.

PMID:
8904520
6.

A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.

Caruso R, Fina D, Peluso I, Stolfi C, Fantini MC, Gioia V, Caprioli F, Del Vecchio Blanco G, Paoluzi OA, Macdonald TT, Pallone F, Monteleone G.

Gastroenterology. 2007 Jan;132(1):166-75. Epub 2006 Oct 1.

PMID:
17241869
7.

Mucosal cytokine imbalance in irritable bowel syndrome.

Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, Tiesman J, Fulmer A, Kiely B, Dinan TG, Shanahan F, Quigley EM.

Scand J Gastroenterol. 2008;43(12):1467-76. doi: 10.1080/00365520802276127.

PMID:
18752146
8.

Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.

Liu Z, Yang L, Cui Y, Wang X, Guo C, Huang Z, Kan Q, Liu Z, Liu Y.

Inflamm Bowel Dis. 2009 Aug;15(8):1133-44. doi: 10.1002/ibd.20923.

PMID:
19322899
9.

Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.

Inoue Y, Tsushima H, Ando K, Sawayama Y, Sakai M, Yamasaki R, Matsuo E, Tsutsumi C, Imaizumi Y, Iwanaga M, Imanishi D, Taguchi J, Miyazaki Y, Tomonaga M.

Exp Hematol. 2006 Jan;34(1):19-26.

PMID:
16413387
10.

Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease.

Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H.

Gastroenterology. 1997 May;112(5):1493-505. Review. Erratum in: Gastroenterology 1997 Aug;113(2):732.

PMID:
9136827
11.

The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation.

Seiderer J, Dambacher J, Kühnlein B, Pfennig S, Konrad A, Török HP, Haller D, Göke B, Ochsenkühn T, Lohse P, Brand S.

Tissue Antigens. 2007 Sep;70(3):238-46.

PMID:
17661913
13.

The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease.

Z'Graggen K, Walz A, Mazzucchelli L, Strieter RM, Mueller C.

Gastroenterology. 1997 Sep;113(3):808-16.

PMID:
9287972
14.

Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.

Shkoda A, Ruiz PA, Daniel H, Kim SC, Rogler G, Sartor RB, Haller D.

Gastroenterology. 2007 Jan;132(1):190-207. Epub 2006 Oct 21.

PMID:
17241871
15.

Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.

Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A.

Clin Exp Immunol. 2007 Sep;149(3):480-6. Epub 2007 Jun 22.

16.

Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome.

Raddatz D, Bockemühl M, Ramadori G.

Eur J Gastroenterol Hepatol. 2005 May;17(5):547-57.

PMID:
15827446
17.

Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes.

Kobayashi T, Okamoto S, Iwakami Y, Nakazawa A, Hisamatsu T, Chinen H, Kamada N, Imai T, Goto H, Hibi T.

Inflamm Bowel Dis. 2007 Jul;13(7):837-46.

PMID:
17285595
18.

Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment.

Lee HJ, Choi SC, Lee MH, Oh HM, Choi EY, Choi EJ, Yun KJ, Seo GS, Kim SW, Lee JG, Han WC, Park KI, Jun CD.

Inflamm Bowel Dis. 2005 Dec;11(12):1070-9.

PMID:
16306769
19.

Butyrate and the cytokine-induced alpha1-proteinase inhibitor release in intestinal epithelial cells.

Faust D, Hormann S, Friedrich-Sander M, Milovic V, Stein J.

Eur J Clin Invest. 2001 Dec;31(12):1060-3.

PMID:
11903492
20.

Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.

Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, Lovecchio M, Gasbarrini G, Cittadini A, Gasbarrini A.

Am J Gastroenterol. 2005 Apr;100(4):886-95.

PMID:
15784037

Supplemental Content

Support Center